Ginsenoside Rk1 inhibits hepatocellular carcinoma progression by activating toxic autophagy and apoptosis via the AMPK/mTOR pathway, presenting a promising new treatment strategy for HCC. This evidence concerns the gene MTOR and hepatocellular carcinoma.